Literature DB >> 28366648

Randomized Controlled Trial Evaluating a Standardized Strategy for Uveitis Etiologic Diagnosis (ULISSE).

Audrey de Parisot1, Laurent Kodjikian2, Marie-Hélène Errera3, Neila Sedira4, Emmanuel Heron4, Laurent Pérard5, Pierre-Loïc Cornut6, Christelle Schneider7, Sophie Rivière8, Priscille Ollé9, Grégory Pugnet10, Pascal Cathébras11, Pierre Manoli12, Bahram Bodaghi13, David Saadoun14, Stéphanie Baillif15, Nathalie Tieulie16, Marc Andre17, Frédéric Chiambaretta18, Nicolas Bonin18, Philip Bielefeld19, Alain Bron20, Frédéric Mouriaux21, Boris Bienvenu22, Stéphanie Vicente23, Sylvie Bin23, Christiane Broussolle24, Evelyne Decullier23, Pascal Sève24.   

Abstract

PURPOSE: To prospectively assess the efficiency of a standardized diagnostic approach, compared to an open strategy, for the etiologic diagnosis of uveitis.
DESIGN: Noninferiority, prospective, multicenter, clustered randomized controlled trial.
METHODS: Consecutive patients with uveitis, who visited 1 of the participating departments of ophthalmology, were included. In the standardized group, all patients had a minimal evaluation regardless of the type of uveitis (complete blood count, erythrocyte sedimentation rate, C-reactive protein, tuberculin skin test, syphilis serology, and chest radiograph) followed by more complex investigations according to ophthalmologic findings. In the open group, the ophthalmologist could order any type of investigation. Main outcome was the percentage of etiologic diagnoses at 6 months.
RESULTS: Nine hundred and three patients with uveitis were included from January 2010 to May 2013 and the per-protocol population comprised 676 patients (open 373; standardized 303). Mean age at diagnosis was 46 years. Anatomic distribution of uveitis was as follows: anterior (60.8% and 72.3%, P = .0017), intermediate (11.7% and 12.3%, P = .8028), posterior (17.8% and 8.2%, P = .0004), and panuveitis (15.3% and 15.2%, P = .9596). An etiologic diagnosis was established in 54.4% of cases in the open group and 49.5% in the standardized group (P = .2029). The difference between both strategies (standardized minus open) was -4.9% (95% CI [-12.5%; 2.6%]). There were more investigations in the open group than in the standardized group (5371 vs 3759, P < .0001).
CONCLUSION: The standardized strategy appears to be an efficient diagnostic approach for the etiologic diagnosis of uveitis, although its noninferiority cannot be proved.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28366648     DOI: 10.1016/j.ajo.2017.03.029

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Increase in Ocular Syphilis Cases at Ophthalmologic Reference Center, France, 2012-2015.

Authors:  Ana Catarina Pratas; Pablo Goldschmidt; David Lebeaux; Claire Aguilar; Natalia Ermak; Jonathan Benesty; Caroline Charlier; Edgar Benveniste; Lilia Merabet; Neila Sedira; Emilie Hope-Rapp; Christine Chaumeil; Bahram Bodaghi; Emmanuel Héron; José-Alain Sahel; Olivier Lortholary; Marie-Hélène Errera
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

2.  Evaluating the cost-consequence of a standardized strategy for the etiological diagnosis of uveitis (ULISSE study).

Authors:  Audrey de Parisot; Yvan Jamilloux; Laurent Kodjikian; Marie-Hélène Errera; Neila Sedira; Emmanuel Heron; Laurent Pérard; Pierre-Loïc Cornut; Christelle Schneider; Sophie Rivière; Priscille Ollé; Grégory Pugnet; Pascal Cathébras; Pierre Manoli; Bahram Bodaghi; David Saadoun; Stéphanie Baillif; Nathalie Tieulie; Marc André; Frédéric Chiambaretta; Nicolas Bonin; Philip Bielefeld; Alain Bron; Frédéric Mouriaux; Boris Bienvenu; Nassira Amamra; Pascale Guerre; Evelyne Decullier; Pascal Sève
Journal:  PLoS One       Date:  2020-02-14       Impact factor: 3.240

3.  Diagnostic value of lymphopaenia and elevated serum ACE in patients with uveitis.

Authors:  Philippine Cotte; Pierre Pradat; Laurent Kodjikian; Yvan Jamilloux; Pascal Seve
Journal:  Br J Ophthalmol       Date:  2020-09-11       Impact factor: 4.638

4.  Risk of Acute Anterior Uveitis in Ankylosing Spondylitis According to the Type of Tumor Necrosis Factor-Alpha Inhibitor and History of Uveitis: A Nationwide Population-Based Study.

Authors:  Soo Min Ahn; Minju Kim; Ye-Jee Kim; Yusun Lee; Yong-Gil Kim
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

5.  Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis.

Authors:  Luca Cantarini; Claudia Fabiani; Francesca Della Casa; Antonio Vitale; Silvana Guerriero; Jurgen Sota; Rolando Cimaz; Gaafar Ragab; Piero Ruscitti; Rosa Maria R Pereira; Francesca Minoia; Emanuela Del Giudice; Giacomo Emmi; Claudia Lomater; Sara Monti; Claudia Canofari; Carla Gaggiano; Giovanni Alessio; Elisabetta Miserocchi; Alessandro Conforti; Marilia A Dagostin; Chiara Mapelli; Maria Pia Paroli; Veronica Parretti; Valeria Albano; Rosa Favale; Luca Marelli; Mohamed Tharwat Hegazy; Paola Cipriani; Isabele P B Antonelli; Valeria Caggiano; Emma Aragona; Ahmed Hatem Laymouna; Gian Marco Tosi; Maria Tarsia; Marco Cattalini; Francesco La Torre; Giuseppe Lopalco; Ewa Więsik-Szewczyk; Micol Frassi; Stefano Gentileschi; Heitor F Giordano; Bruno Frediani; Samuel K Shinjo; Donato Rigante; Petros P Sfikakis; Alberto Balistreri; Mohamed A Hussein; Rana Hussein Amin
Journal:  Ophthalmol Ther       Date:  2022-01-31

6.  Management of Non-Infectious Uveitis, a Selection of Topical Items Updating.

Authors:  Pascal Sève; Thomas El Jammal; Mathieu Gerfaud-Valentin; Laurent Kodjikian; Yvan Jamilloux; Robin Jacquot
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

Review 7.  French recommendations for the management of Behçet's disease.

Authors:  Isabelle Kone-Paut; Stéphane Barete; Bahram Bodaghi; Kumaran Deiva; Anne-Claire Desbois; Caroline Galeotti; Julien Gaudric; Gilles Kaplanski; Alfred Mahr; Nicolas Noel; Maryam Piram; Tu-Anh Tran; Bertrand Wechsler; David Saadoun
Journal:  Orphanet J Rare Dis       Date:  2021-02-24       Impact factor: 4.123

8.  Cytokines, chemokines and growth factors profile in human aqueous humor in idiopathic uveitis.

Authors:  Marie-Hélène Errera; Ana Pratas; Sylvain Fisson; Thomas Manicom; Marouane Boubaya; Neila Sedira; Emmanuel Héron; Lilia Merabet; Alfred Kobal; Vincent Levy; Jean-Michel Warnet; Christine Chaumeil; Françoise Brignole-Baudouin; José-Alain Sahel; Pablo Goldschmidt; Bahram Bodaghi; Coralie Bloch-Queyrat
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.